OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From Thalidomide to Rational Molecular Glue Design for Targeted Protein Degradation
Vladas Oleinikovas, Pablo Gaínza, Thomas Ryckmans, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 291-312
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Targeted protein degradation: from mechanisms to clinic
Jonathan M. Tsai, Radosław P. Nowak, Benjamin L. Ebert, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 9, pp. 740-757
Closed Access | Times Cited: 81

Continuous evolution of compact protein degradation tags regulated by selective molecular glues
Jaron A. M. Mercer, Stephan J. DeCarlo, Shourya S. Roy Burman, et al.
Science (2024) Vol. 383, Iss. 6688
Open Access | Times Cited: 20

Targeting protein–ligand neosurfaces with a generalizable deep learning tool
Anthony Marchand, Stephen Buckley, Arne Schneuing, et al.
Nature (2025)
Open Access | Times Cited: 1

Leveraging Structural and Computational Biology for Molecular Glue Discovery
CongBao Kang, Weijun Xu
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1

Benchmarking Methods for PROTAC Ternary Complex Structure Prediction
Evianne Rovers, Matthieu Schapira
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 15, pp. 6162-6173
Closed Access | Times Cited: 9

Molecular glue degraders: exciting opportunities for novel drug discovery
Thomas Lemaître, Marie Cornu, Florian Schwalen, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 4, pp. 433-449
Closed Access | Times Cited: 8

Mechanism of degrader-targeted protein ubiquitinability
Charlotte Crowe, Mark A. Nakasone, Sarah Chandler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7

Emerging strategies for prospective discovery of molecular glue degraders
Baiyun Wang, Shiyun Cao, Ning Zheng
Current Opinion in Structural Biology (2024) Vol. 86, pp. 102811-102811
Closed Access | Times Cited: 7

Expanding the ligand spaces for E3 ligases for the design of protein degraders
Rahman Shah Zaib Saleem, Martin P. Schwalm, Stefan Knapp
Bioorganic & Medicinal Chemistry (2024) Vol. 105, pp. 117718-117718
Open Access | Times Cited: 7

Targeted protein degradation in CNS disorders: a promising route to novel therapeutics?
Sandra Kuemper, Andrew G. Cairns, Kristian Birchall, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 6

Machine learning proteochemometric models for Cereblon glue activity predictions
Francis J. Prael, Jiayi Cox, Noé Sturm, et al.
Artificial Intelligence in the Life Sciences (2024) Vol. 6, pp. 100100-100100
Open Access | Times Cited: 5

Unveiling the hidden interactome of CRBN molecular glues with chemoproteomics
Kheewoong Baek, Rebecca J. Metivier, Shourya S. Roy Burman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5

Discovery of novel benzosultam CRBN ligands
Hoyeong Park, Santosh Shivanand Raikar, Yonghyo Kim, et al.
Bulletin of the Korean Chemical Society (2025)
Closed Access

Cullin-RING ligase BioE3 reveals molecular-glue-induced neosubstrates and rewiring of the endogenous Cereblon ubiquitome
Laura Merino‐Cacho, Orhi Barroso‐Gomila, Mónica Pozo-Rodríguez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Identification of MORF4L1 as an endogenous substrate of CRBN and its potential role as a therapeutic target in cancer
Luyao Zhang, Shunfang Liu, Jingliang He, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Unleashing the Power of Covalent Drugs for Protein Degradation
Meng‐Jie Fu, Hang Jin, Shao‐Peng Wang, et al.
Medicinal Research Reviews (2025)
Closed Access

Design and Discovery of Preclinical Candidate LYG-409 as a Highly Potent and Selective GSPT1 Molecular Glue Degraders
Yanqing Zhang, Wenjing Liu, Chao Tong, et al.
Journal of Medicinal Chemistry (2025)
Closed Access

Unraveling the Engagement of Kinases to CRBN Through a Shared Structural Motif to Optimize PROTACs Efficacy
Serena Rosignoli, Silvia Giordani, M Pacelli, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 206-206
Open Access

A Comprehensive Overview of Protacs Targeting Hsp90 and Their Client Proteins for Cancer Therapy
Gulshan Kumar, Gouri Tyagi, Vikramdeep Monga
(2025)
Closed Access

Cullin-RING ligase BioE3 reveals molecular-glue-induced neosubstrates and rewiring of the endogenous Cereblon ubiquitome
Laura Merino‐Cacho, Orhi Barroso‐Gomila, Mónica Pozo-Rodríguez, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access

In silico modeling of targeted protein degradation
Wenxing Lv, Xiaojuan Jia, Bowen Tang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117432-117432
Open Access

Allostery in Disease: Anticancer Drugs, Pockets, and the Tumor Heterogeneity Challenge
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Journal of Molecular Biology (2025), pp. 169050-169050
Open Access

The “three body solution”: Structural insights into molecular glues
Aidan C.A. Tomlinson, John E. Knox, Luc Brunsveld, et al.
Current Opinion in Structural Biology (2025) Vol. 91, pp. 103007-103007
Open Access

Discovery of Molecular Glue Degraders via Isogenic Morphological Profiling
Amanda Hui Qi Ng, Fabian Offensperger, José A. Cisneros, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 12, pp. 2464-2473
Open Access | Times Cited: 13

Page 1 - Next Page

Scroll to top